Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-10 · accession 0001171843-26-001463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-10 | EDSA | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $6.60 | +1,000 | 628.8K | +0.2% | +$6,600 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-03-10 | P | A | 1,000 | $6.60 | 628,813 | D | — | — |